Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 71Pancreatic Neoplasms 69Colorectal Neoplasms 26Liver Neoplasms 20Neoplasm Metastasis 9Lung Neoplasms 8Melanoma 7Cholangiocarcinoma 6Sarcoma 5Neoplasms 5Colonic Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Gastrointestinal Neoplasms 4Esophageal Neoplasms 4Carcinoma, Renal Cell 4Brain Neoplasms 4Klatskin Tumor 3Urinary Bladder Neoplasms 2Unresectable Locally Recurrent Rectal Cancer 2Thyroid Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Locally Advanced Pancreatic Cancer 2Carcinoma, Non-Small-Cell Lung 2Bile Duct Neoplasms 2Adrenal Gland Neoplasms 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Spinal Cord Compression 1

Interventions

Radiosurgery 2Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unresectable Locally Recurrent Rectal Cancer × Radiosurgery × Gastrointestinal × Clear all
NCT07297004 2026-04-24

Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
20 enrolled
Gastrointestinal

Unresectable Locally Recurrent Rectal Cancer

NCT06767007 2026-04-23

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer(SPARKLE)

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
31 enrolled
Gastrointestinal

Unresectable Locally Recurrent Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡